Serious Gaming for Chemotherapy-induced Nausea and Vomiting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of Central Florida
About this trial
The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.
Eligibility criteria
Qualifiers
age 60 or older
newly diagnosed with cancer
treatment with any chemotherapeutic agent of moderate or high emetic potential
on a 2, 3 or 4 week treatment cycle
Disqualifiers
previous diagnosis and/or treatment for cancer
end stage disease with less than 6 months to live
visually or hearing impaired without corrective device
Trial design
Treatments tested in this trial
- eSSET-CINV
Treatment groups
610 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Central Florida
Lead sponsor
Orlando Health, Inc.
Collaborator
University of Miami
Collaborator
National Institute of Nursing Research (NINR)
Collaborator
Source ClinicalTrials.gov